簡易檢索 / 詳目顯示
| 研究生： |
邱翰昇 Chiu, Han-Sheng |
|---|---|
| 論文名稱： |
中小企業股票初次公開發行之挑戰 : 以H生技公司為例 The challenge of small and medium enterprise for initial public offering: a case of h biotechnology company |
| 指導教授： |
吳文傑
Wu, Jack |
| 學位類別： |
碩士
Master |
| 系所名稱： |
商學院 - 國際經營管理英語碩士學位學程(IMBA) International MBA Program College of Commerce(IMBA) |
| 論文出版年： | 2018 |
| 畢業學年度： | 106 |
| 語文別： | 英文 |
| 論文頁數： | 84 |
| 中文關鍵詞： | 首次公開募股 、中小型企業 |
| 外文關鍵詞： | IPO, SME |
| 相關次數： | 點閱：32 下載：16 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
The purpose of this thesis is to check the readiness of a medium size family company, H Biotechnology Company, for initial public offering (IPO). In recent, like most of small and medium size companies, H Company faces a bottleneck to grow due to difficulties of recruiting suitable elites as well as raising money from financing channels. Moreover, it is also not an easy task for an unknown medium size company to initiate transactions with big or foreign companies that did not have any cooperation experience before; however, it is the road a medium size company must take in order to grow well. Therefore, IPO is an option that H Company must take into consideration. Starting from preparation to IPO, the company will scan itself from bottom up thoroughly and make positive changes accordingly throughout the process. Once IPO successfully, there will be more chances and resources for the company to recruit talents and grow. Through preliminary scan in this thesis, hope to point out some parts that H Company has to improve in order to IPO in the near future.
1. Executive Summary 1
1.1 Purpose 1
1.2 Small and Medium Enterprise in Taiwan 1
1.3 Capital Market in Taiwan 2
1.4 The Company 3
1.5 The Industry 3
1.6 The Competitor 4
1.7 The Customer 5
1.8 The Management 5
1.9 The Financials 6
1.10 The IPO Evaluation 6
1.11 Brief Summary 7
2. Small and Medium Enterprise in Taiwan 8
2.1 Role and Trend 8
2.2 Length of Existence 13
2.3 Distribution by Industry 15
2.4 Funding 16
2.5 Challenges 17
3. Capital Market in Taiwan 19
3.1 Capital Markets Overview 19
3.2 Stepwise review to each level markets 20
4. The Company 25
4.1 Vision and Mission 25
4.2 History 25
4.3 Location 26
4.4 Organization Structure 26
4.5 Products and Business Model 28
4.6 Shareholders 29
4.7 Bottleneck and Why IPO 29
5. The Industry 31
5.1 Evolution of Biotechnology Industry in Taiwan 31
5.2 Statistical Data of the Industry 32
5.3 H Company in the Industry 33
6. The Competitor 34
6.1 Medical Products 34
6.2 Cosmetics Products 34
6.3 Conclusions 38
7. The Customer 40
7.1 Target Customers and Needs 40
7.2 Fulfilments of Customer Needs 40
8. The Management 42
9. The Financials 45
9.1 Financial Positions 45
9.2 Income Performance 46
9.3 Pro-forma Financial Performance 49
9.4 Conclusion 59
10. The IPO Evaluation 62
10.1 IPO Evaluation 62
10.2 Plan 65
10.3 Conclusions 68
Reference 69
Appendix 70
1. Regulations from Taiwan Stock Exchange (http://www.twse.com.tw)
2. Regulations from Taipei Exchange (http://www.tpex.org.tw)
3. 2017生技產業白皮書 by經濟部生技醫藥產業發展推動小組(http://www.biopharm.org.tw)
4. 2017 中小企業白皮書 by 經濟部中小企業處(http://www.moeasmea.gov.tw)
